REGID - Dr. G Milligan,“New approaches to study GPR35; a novel target for the treatment of diabetes” (2009)
Dr. G Milligan,“New approaches to study GPR35; a novel target for the treatment of diabetes” (2009)
Dr. G Milligan, Department of Neuroscience and Molecular Pharmacology. University of Glasgow. “New approaches to study GPR35; a novel target for the treatment of diabetes”, 2009.

Entidades Financiadoras:
EntidadesFinanciadoras.png
 
 

Red Gallega de Investigación y Desarrollo de Medicamentos (REGID)

Edificio CIMUS, Planta 3ª Av. Barcelona S/N, USC

15703, Santiago de Compostela, España

Tel: +34 881 811 000 (ext 15459)

Fax: +34 881 815 474